Crystal structure made easy

Credit: Courtesy of the International Union of Crystallography" /> Credit: Courtesy of the International Union of Crystallography Crystallizing proteins is a daunting task. Last year Alexander McPherson of the University of California, Irvine, and colleagues proposed a novel strategy to develop crystals quickly by including high concentrations of small molecules to the so-called mother liquors. They analyzed data on the crystallization of 81 different protein cultur

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Crystallizing proteins is a daunting task. Last year Alexander McPherson of the University of California, Irvine, and colleagues proposed a novel strategy to develop crystals quickly by including high concentrations of small molecules to the so-called mother liquors. They analyzed data on the crystallization of 81 different protein cultured in the presence of small molecules that could serve as ligands and potentially promote lattice formation. Recently they examined nine of those crystal structures and looked for evidence that the small molecules indeed aided crystallization.1

Small molecule cocktails helped in many cases. In two particular instances, RNase A and bovine trypsin, researchers saw that the bioactive compounds in the reagent mixtures were nearly wholly responsible for creating the unique crystal forms that had never before been observed.

?This work confirms the validity of a new crystallization strategy.? writes Faculty of 1000 member Fred Dyda of the National Institutes of Health. ?The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies